Studies in tamoxifen-resistant MCF-7 breast cancer cells identified that ZIP7 was responsible for activation of multiple tyrosine kinases that are implicated in the aggressive phenotype of tamoxifen-resistant breast cancer [8], [19], [20]. The gene discussed is SLC39A7; the disease is breast carcinoma.